NCT00861744 · Interventional trial
Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age
Overall registry status Completed
Phase 2
Conditions Measles, Measles-Mumps-Rubella Vaccine, Mumps, Rubella
Delaware Valley sites
- GSK Investigational Site · East Norriton, PA · Montgomery County
- GSK Investigational Site · Rydal, PA · Montgomery County
First posted
Registry updated
Added to the directory